文献速递泌尿生殖与妇科肿瘤放疗

帮助患者做出知情决策:居斯塔夫·鲁西前列腺癌多学科门诊两年评估

Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinic.
PubMed 文献 · Clin Transl Radiat Oncol · 2018-07-06

该研究评估了居斯塔夫·鲁西前列腺癌多学科门诊(PCMC)最初两年的活动,该门诊由泌尿外科医生和放射肿瘤科医生连续会诊后经专门肿瘤委员会讨论,针对非转移性前列腺癌的初始治疗决策。对195例符合条件患者的病历和问卷进行分析,问卷回复率69%(134例),完全满意率高(118例回复者中114例,97%),55%的病例获得了新的治疗选择,46%的患者(125例中57例)在PCMC会诊后改变了前列腺癌管理决策。

要点

  • PCMC由泌尿外科医生和放射肿瘤科医生连续会诊及专门肿瘤委员会讨论组成。
  • 问卷回复率69%(134例),完全满意率97%(118例中114例)。
  • 46%的患者(125例中57例)在PCMC会诊后改变了前列腺癌管理决策。

核心结论

  • 非转移性前列腺癌初始管理的多学科会诊经验带来高患者满意度,改善患者对信息充分的感受,促进主动参与和共享决策,并强烈影响其最终决策。

研究设计与样本

  • 对居斯塔夫·鲁西前列腺癌多学科门诊(PCMC)最初两年活动的评估,PCMC由泌尿外科医生和放射肿瘤科医生连续会诊后经专门肿瘤委员会讨论组成,通过邮寄问卷对全部PCMC患者进行调查,分析195例符合条件患者的病历和问卷回复。

主要发现

  • 问卷回复率为69%(134例患者)。
  • 完全满意率高(118例回复者中114例,97%)。
  • 55%的病例获得了新的治疗选择,98%的患者(125例回复者中122例)感觉信息更充分。
  • 双重会诊被认为有用(129例回复者中124例,96%),主动参与感显著升高(131例回复者中117例,89%)。
  • 46%的患者(125例中57例)在PCMC会诊后改变了前列腺癌管理决策。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The initial treatment decision for newly diagnosed non-metastatic prostate cancer is complex. Multiple valid approaches exist, without a clear and absolute consensus for every clinical scenario, and therefore specialist opinions may vary. Multidisciplinary consultations focusing on shared decision-making aim to provide an apposite tool for the initial treatment decision. We have evaluated the first two years of activity of the Gustave Roussy Prostate Cancer Multidisciplinary Clinic (PCMC), dedicated to the initial decision-making for non-metastatic prostate cancer. METHODS: PCMC consists of two consecutive specialist consultations with a urological surgeon and a radiation oncologist, followed by a dedicated Tumor Board discussion. A study questionnaire was addressed to all PCMC patients via postal mail. Medical notes and questionnaire responses of 195 eligible patients were analyzed. RESULTS: The questionnaire response rate was 69% (134 patients). Complete satisfaction rate was high (114 of 118 responders, 97%). Patients were offered new treatment options in 55% of cases, and felt better informed in 98% (122 of 125 responders). The double consultation was considered useful (124 of 129 responders, 96%). Reported feeling of active participation was significantly elevated (117 of 131 responders, 89%), while 46% of patients (57 of 125) modified their decision on the management of their prostate cancer following their PCMC consultation. CONCLUSIONS: The experience of a multidisciplinary consultation in the initial management of non-metastatic prostate cancer renders high patient satisfaction, improves their appreciation of feeling better informed, promotes active participation and shared decision-making and strongly influences their final decision.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Patrikidou A, Maroun P, Patard JJ, et al. Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinic. Clin Transl Radiat Oncol. 2018. PMID: 30094353. doi:10.1016/j.ctro.2018.07.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。